Related Experiment Video
Updated: Jun 13, 2026

09:51
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Targeting TLR/IL-1R signalling in human diseases
Maria Loiarro1, Vito Ruggiero, Claudio Sette
1Department of Public Health and Cell Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
Mediators of Inflammation
|April 17, 2010
Summary
Toll-like receptor/interleukin (IL)-1 receptor (TLR/IL-1R) superfamily proteins are key in immune responses. Inhibitors targeting TLR/IL-1R signaling show promise for treating inflammatory and autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Toll-like receptor/interleukin (IL)-1 receptor (TLR/IL-1R) superfamily proteins are crucial regulators of the immune response.
- Aberrant TLR/IL-1R signaling contributes to inflammatory and autoimmune diseases.
Purpose of the Study:
- To review the structural and functional aspects of TLR/IL-1R proteins.
- To discuss recent advances in developing therapeutic drugs targeting TLR/IL-1R signaling.
Main Methods:
- Focus on inhibitors like decoy peptides and synthetic mimetics.
- Analysis of protein-protein interactions within TLR/IL-1R signaling pathways.
Main Results:
- Decoy peptides and synthetic mimetics interfere with TLR/IL-1R signaling.
- These inhibitors represent a novel therapeutic approach.
Conclusions:
- Pharmaceutical modulation of TLR/IL-1R pathways offers potential clinical benefits.
- Targeting TLR/IL-1R signaling may be effective for inflammatory and autoimmune diseases.
Related Concept Videos
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

